Fortrea

Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners

4 June 2024 -- North Carolina, US -- Fortrea a leading global contract research organisation (CRO), today announced it has completed the divestiture of assets relating to its Enabling Services segment, namely its Endpoint Clinical (Endpoint) and Fortrea Patient Access (FPA) businesses, to Arsenal Capital Partners (Arsenal), a leading private equity firm specialising in building market-leading,...
8 Moore Drive Durham, NC 27703

877-495-0816